Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole Versus Observation in Newly Diagnosed Uterine Leiomyosarcoma
NCT05649956Phase 2Recruiting
- Sponsor
- GOG Foundation
- Start
- Jul 2024
- Primary completion
- Jul 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in uterine leiomyosarcoma (uLMS), sponsored by GOG Foundation. Started Jul 2024; status: recruiting.
02
Drugs
letrozole
03
Conditions
uterine leiomyosarcoma (uLMS)
Beyond the preview
Go deeper on NCT05649956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05649956.